Mangoceuticals, Inc. (MGRX)Healthcare | Health Information Services | Dallas, United States | NasdaqCM
0.32 USD
-0.01
(-2.015%) ⇩
(Oct. 15, 2026, 4 p.m.
EDT)
After hours: 0.32 +0.00 (1.090%) ⇧ (Oct. 15, 2026, 7:29 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 5:04 a.m. EDT
The immediate outlook is clouded by severe structural damage to the business, despite recent price volatility. The company is hemorrhaging value with a 59% drop in revenue, negative operating margins of over 15%, and a crushing return on equity of nearly -95%. The balance sheet is precarious, holding less than a quarter of a dollar in cash against debt exceeding $279,000, resulting in a current ratio of just 0.176. While the stock recently rallied on news of testosterone injection sales, the underlying fundamentals tell a story of a failing operation where free cash flow is negative and the market has already priced in a catastrophic decline, evidenced by a 75% drop over the last two years. With no dividend history and a trajectory of continuous deterioration, there is no rational basis for a long-term investment. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.233988 |
| MSTL | 0.257748 |
| AutoTheta | 0.275105 |
| AutoARIMA | 0.914200 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 1.74 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.981 |
| Excess Kurtosis | 0.12 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.229 |
| Revenue per Share | 0.021 |
| Market Cap | 7,134,039 |
| Beta | 1.98 |
| Website | https://www.mangoceuticals.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8666667 |
| Address1 | 17,130 N. Dallas Parkway |
| Address2 | Suite 240 |
| All Time High | 65.55 |
| All Time Low | 0.162 |
| Ask | 0.4414 |
| Ask Size | 7 |
| Average Daily Volume10 Day | 750,340 |
| Average Daily Volume3 Month | 12,814,667 |
| Average Volume | 12,814,667 |
| Average Volume10Days | 750,340 |
| Beta | 1.983 |
| Bid | 0.3053 |
| Bid Size | 2 |
| Book Value | 0.695 |
| City | Dallas |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.321 |
| Current Ratio | 0.176 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 0.3624 |
| Day Low | 0.3201 |
| Debt To Equity | 2.229 |
| Display Name | Mangoceuticals |
| Dividend Yield | 0.0 |
| Ebitda | -12,097,073 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.576 |
| Enterprise To Revenue | 22.116 |
| Enterprise Value | 6,971,641 |
| Eps Trailing Twelve Months | -0.89 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.43654 |
| Fifty Day Average Change | -0.11554 |
| Fifty Day Average Change Percent | -0.2646722 |
| Fifty Two Week Change Percent | -86.666664 |
| Fifty Two Week High | 2.75 |
| Fifty Two Week High Change | -2.429 |
| Fifty Two Week High Change Percent | -0.8832727 |
| Fifty Two Week Low | 0.162 |
| Fifty Two Week Low Change | 0.15900001 |
| Fifty Two Week Low Change Percent | 0.98148155 |
| Fifty Two Week Range | 0.162 - 2.75 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,679,405,400,000 |
| Float Shares | 15,803,528 |
| Free Cashflow | 1,268,902 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 3 |
| Fullday Change | -0.0031000078 |
| Fullday Change Percent | -0.94627833 |
| Fullday Price | 0.321 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.54433995 |
| Gross Profits | 171,590 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.17608 |
| Held Percent Institutions | 0.05465 |
| Implied Shares Outstanding | 22,224,422 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Ipo Expected Date | 2,023-03-21 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,729,036,800 |
| Last Split Factor | 1:15 |
| Long Business Summary | Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc. |
| Long Name | Mangoceuticals, Inc. |
| Market | us_market |
| Market Cap | 7,134,039 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1787930606 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -16,279,588 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 9,792,687 |
| Open | 0.3381 |
| Operating Cashflow | -3,890,874 |
| Operating Margins | -15.02451 |
| Phone | 214 242 9619 |
| Post Market Change | 0.0034999847 |
| Post Market Change Percent | 1.0903379 |
| Post Market Price | 0.3245 |
| Post Market Time | 1,792,106,967 |
| Previous Close | 0.3276 |
| Price Hint | 4 |
| Price To Book | 0.46187052 |
| Price To Sales Trailing12 Months | 22.631433 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.164 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00659999 |
| Regular Market Change Percent | -2.01465 |
| Regular Market Day High | 0.3624 |
| Regular Market Day Low | 0.3201 |
| Regular Market Day Range | 0.3201 - 0.3624 |
| Regular Market Open | 0.3381 |
| Regular Market Previous Close | 0.3276 |
| Regular Market Price | 0.321 |
| Regular Market Time | 1,792,094,401 |
| Regular Market Volume | 663,696 |
| Return On Assets | -0.46965998 |
| Return On Equity | -0.95098 |
| Revenue Growth | -0.591 |
| Revenue Per Share | 0.021 |
| Sand P52 Week Change | 0.16440773 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 22,224,422 |
| Shares Percent Shares Out | 0.020299999 |
| Shares Short | 438,786 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 632,502 |
| Short Name | Mangoceuticals, Inc. |
| Short Percent Of Float | 0.0221 |
| Short Ratio | 0.91 |
| Source Interval | 15 |
| State | TX |
| Symbol | MGRX |
| Total Cash | 228,688 |
| Total Cash Per Share | 0.011 |
| Total Debt | 279,207 |
| Total Revenue | 315,227 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.89 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.438635 |
| Two Hundred Day Average Change | -0.11763498 |
| Two Hundred Day Average Change Percent | -0.2681842 |
| Type Disp | Equity |
| Volume | 663,696 |
| Website | https://www.mangoceuticals.com |
| Zip | 75,248 |